{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:45:12Z","timestamp":1793335512665,"version":"4.5.0"},"reference-count":128,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The assessment of quality of life (QoL) in patients with psoriasis plays a crucial role in understanding the impact of the disease and evaluating treatment outcomes. We provide an overview of the key measures used to assess QoL in psoriasis patients, including both generic and psoriasis-specific instruments. The limitations and strengths of instruments such as the Dermatology Life Quality Index (DLQI), Skindex, and Psoriasis Disability Index (PDI) are discussed, highlighting their psychometric properties and areas for improvement. Furthermore, this review examines the potential of disease-specific QoL measures in providing greater sensitivity to disease-related burden and change compared to generic instruments. However, most of the available psoriasis-specific patient-reported outcome measures need further validation. We aim to provide valuable insights into the importance of using validated QoL measures in clinical practice and research, ultimately contributing to a more comprehensive assessment of the impact of psoriasis on patients\u2019 lives and enhancing the evaluation of treatment interventions.<\/jats:p>","DOI":"10.3390\/jcm13164623","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T11:33:52Z","timestamp":1723030432000},"page":"4623","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Health-Related Quality of Life in Psoriasis: Literature Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Gioele","family":"Ghezzi","sequence":"first","affiliation":[{"name":"Humanitas University, 20072 Pieve Emanuele, MI, Italy"},{"name":"Dermatology Unit, Humanitas Research Hospital\u2014IRCCS, 20089 Rozzano, MI, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Costanzo","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Humanitas Research Hospital\u2014IRCCS, 20089 Rozzano, MI, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5704-1220","authenticated-orcid":false,"given":"Riccardo G.","family":"Borroni","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Humanitas Research Hospital\u2014IRCCS, 20089 Rozzano, MI, Italy"},{"name":"Department of Biomedical Sciences, Humanitas University, 20072 Pieve Emanuele, MI, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00221-009-2007-y","article-title":"The skin as a social organ","volume":"204","author":"Morrison","year":"2010","journal-title":"Exp. Brain Res."},{"key":"ref_2","first-page":"195","article-title":"Le Moi-Peau","volume":"9","author":"Anzieu","year":"1974","journal-title":"Nouv. Rev. Psychanal."},{"key":"ref_3","unstructured":"World Health Organization (2024, June 28). WHOQOL: Measuring Quality of Life. Available online: https:\/\/www.who.int\/tools\/whoqol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/jid.2013.513","article-title":"An insight into the global burden of skin diseases","volume":"134","author":"Hollestein","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_5","first-page":"243","article-title":"Measuring quality of life: Apparent benefits, potential concerns","volume":"4","author":"Till","year":"1994","journal-title":"Can. J. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"McKenna, S.P. (2011). Measuring patient-reported outcomes: Moving beyond misplaced common sense to hard science. BMC Med., 9.","DOI":"10.1186\/1741-7015-9-86"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","article-title":"Psoriasis causes as much disability as other major medical diseases","volume":"41","author":"Rapp","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1477-7525-7-62","article-title":"The impact of itch symptoms in psoriasis: Results from physician interviews and patient focus groups","volume":"7","author":"Globe","year":"2009","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2133.2004.06093.x","article-title":"Prevalence of symptoms experienced by patients with different clinical types of psoriasis","volume":"151","author":"Sampogna","year":"2004","journal-title":"Br. J. Dermatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0190-9622(03)01136-8","article-title":"Quality of life issues in psoriasis","volume":"49","author":"Choi","year":"2003","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2340\/00015555-0764","article-title":"Skin pain and discomfort in psoriasis: An exploratory study of symptom prevalence and characteristics","volume":"90","author":"Ljosaa","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2340\/00015555-1273","article-title":"Living with psoriasis: Prevalence of shame, anger, worry, and problems in daily activities and social life","volume":"92","author":"Sampogna","year":"2012","journal-title":"Acta Derm. Venereol."},{"key":"ref_13","first-page":"138","article-title":"Alcohol consumption and psychological distress in patients with psoriasis","volume":"158","author":"Kirby","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1440-0960.2004.00078.x","article-title":"Psychiatric morbidity in psoriasis: A review","volume":"45","author":"Russo","year":"2004","journal-title":"Australas. J. Dermatol."},{"key":"ref_15","first-page":"e9708","article-title":"Association Between Psoriasis and Depression: A Traditional Review","volume":"12","author":"Sahi","year":"2020","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1067\/mjd.2002.122755","article-title":"Quantifying the harmful effect of psoriasis on health-related quality of life","volume":"47","author":"Weiss","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/13548506.2020.1766093","article-title":"An evaluating of the relationship between body image, body satisfaction, depression, marital quality, and self-esteem in patients with psoriasis","volume":"26","author":"Hassani","year":"2021","journal-title":"Psychol. Health Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2017.05.019","article-title":"Psoriasis and suicidality: A systematic review and meta-analysis","volume":"77","author":"Singh","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archderm.138.3.337","article-title":"Association of dissatisfaction with care and psychiatric morbidity with poor treatment compliance","volume":"138","author":"Renzi","year":"2002","journal-title":"Arch. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000313825","article-title":"Time needed for treatment is the major predictor of quality of life in psoriasis","volume":"221","author":"Blome","year":"2010","journal-title":"Dermatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1517\/17425247.2012.711756","article-title":"Topical drug delivery systems in dermatology: A review of patient adherence issues","volume":"9","author":"Tan","year":"2012","journal-title":"Expert. Opin. Drug Deliv."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1046\/j.1365-2133.2001.04444.x","article-title":"Social coping strategies associated with quality of life decrements among psoriasis patients","volume":"145","author":"Rapp","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-4362.1993.tb05031.x","article-title":"Psychosocial consequences of rejection and stigma feelings in psoriasis patients","volume":"32","author":"Ginsburg","year":"1993","journal-title":"Int. J. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/archderm.141.12.1527","article-title":"Impact of obesity and smoking on psoriasis presentation and management","volume":"141","author":"Herron","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.amjmed.2007.12.007","article-title":"High incidence of smoking habit in psoriatic patients","volume":"121","author":"Favato","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/jdv.14865","article-title":"The relationship between clinical characteristics including presence of exposed lesions and health-related quality of life (HRQoL) in patients with psoriasis: Analysis from the nationwide epidemiologic study for psoriasis in Korea (EPI-PSODE study)","volume":"32","author":"Youn","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1046\/j.1468-3083.2001.00336.x","article-title":"Increased psychiatric morbidity in female outpatients with skin lesions on visible parts of the body","volume":"81","author":"Picardi","year":"2001","journal-title":"Acta Derm. Venereol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaad.2004.04.014","article-title":"Determinants of quality of life in patients with psoriasis: A study from the US population","volume":"51","author":"Gelfand","year":"2004","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_29","first-page":"15","article-title":"The psychological and social burdens of psoriasis","volume":"17","author":"Young","year":"2005","journal-title":"Dermatol. Nurs."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jaad.2019.08.026","article-title":"Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council","volume":"82","author":"Strober","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/1346-8138.12201","article-title":"Identification of psoriatic patients at risk of high quality of life impairment","volume":"40","author":"Majcan","year":"2013","journal-title":"J. Dermatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ad.2022.07.021","article-title":"Quality of Life and Body Region Affected by Psoriasis: A Systematic Review","volume":"114","author":"Nabieva","year":"2023","journal-title":"Actas Dermosifiliogr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00403-016-1637-8","article-title":"The German National Program on Psoriasis Health Care 2005\u20132015: Results and experiences","volume":"308","author":"Augustin","year":"2016","journal-title":"Arch. Dermatol. Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2133.2009.09515.x","article-title":"Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: Update of the EDEN Psoriasis Survey 2001\u20132006","volume":"162","author":"Naldi","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1038\/sj.jid.5701081","article-title":"Why are quality of life instruments not recognized as reference measures in therapeutic trials of chronic skin disorders?","volume":"127","author":"Grob","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.det.2004.03.016","article-title":"Quality-of-life issues in psoriasis","volume":"22","author":"Mukhtar","year":"2004","journal-title":"Dermatol. Clin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(09)61400-8","article-title":"Use of patient-reported outcomes in clinical practice","volume":"374","author":"Snyder","year":"2009","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","article-title":"Implementing patient-reported outcomes assessment in clinical practice: A review of the options and considerations","volume":"21","author":"Snyder","year":"2012","journal-title":"Qual. Life Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"f167","DOI":"10.1136\/bmj.f167","article-title":"Patient reported outcome measures could help transform healthcare","volume":"346","author":"Black","year":"2013","journal-title":"BMJ"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s11136-008-9379-5","article-title":"Prospects and challenges in using patient-reported outcomes in clinical practice","volume":"17","author":"Fung","year":"2008","journal-title":"Qual. Life Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2009.03563.x","article-title":"What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature","volume":"24","author":"Bronsard","year":"2010","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/bmj.4.5840.585","article-title":"Long-term effects of hydroxyurea in psoriases","volume":"4","author":"Dahl","year":"1972","journal-title":"Br. Med. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10 years experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J. Investig. Dermatol. Symp. Proc."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00403-017-1794-4","article-title":"Is the DLQI appropriate for medical decision-making in psoriasis patients?","volume":"310","author":"Brodszky","year":"2018","journal-title":"Arch. Dermatol. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): Further data","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1111\/jdv.16915","article-title":"EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris\u2014Part 1: Treatment and monitoring recommendations","volume":"34","author":"Nast","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Madrigal-Cadavid, J., Estrada-Acevedo, J., Maria Jaramillo, A., Jaramillo-Santacoloma, L., Guarin, S., Londo\u00f1o, A., and Rojas-Gualdron, D. (2024). Rasch analysis of the dermatology life quality index (DLQI) in patients with mild to moderate-severe psoriasis. Indian. J. Dermatol. Venereol. Leprol., 1\u20137.","DOI":"10.25259\/IJDVL_271_2022"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-7525-4-71","article-title":"The validity and responsiveness of three quality of life measures in the assessment of psoriasis patients: Results of a phase II study","volume":"4","author":"Shikiar","year":"2006","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_50","first-page":"199","article-title":"Analysis of the relationship between psoriasis symptom severity and quality of life, work productivity, and activity impairment among patients with moderate-to-severe psoriasis using structural equation modeling","volume":"7","author":"Abouzaid","year":"2013","journal-title":"Patient Prefer. Adherence"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000119415","article-title":"Disease severity, quality of life and health care in plaque-type psoriasis: A multicenter cross-sectional study in Germany","volume":"216","author":"Augustin","year":"2008","journal-title":"Dermatology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0031-9384(00)00290-0","article-title":"The psychosocial impact of psoriasis: Physical severity, quality of life, and stigmatization","volume":"70","author":"Perrott","year":"2000","journal-title":"Physiol. Behav."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/j.1365-2133.2007.07817.x","article-title":"The Dermatology Life Quality Index: Assessing the efficacy of biological therapies for psoriasis","volume":"156","author":"Katugampola","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_54","first-page":"e507","article-title":"Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coru\u00f1a, Spain","volume":"53","author":"Fonseca","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.medici.2016.07.001","article-title":"Associations of the quality of life and psychoemotional state with sociodemographic factors in patients with psoriasis","volume":"52","year":"2016","journal-title":"Medicina"},{"key":"ref_56","first-page":"186","article-title":"Quality of life in patients with psoriasis in northern Taiwan","volume":"34","author":"Lin","year":"2011","journal-title":"Chang. Gung Med. J."},{"key":"ref_57","first-page":"709","article-title":"The quality of life in Italian psoriatic patients treated with biological drugs","volume":"145","author":"Cozzani","year":"2010","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1468-3083.2011.04082.x","article-title":"Impact of ustekinumab on health-related quality of life and sexual difficulties associated with psoriasis: Results from two phase III clinical trials","volume":"25","author":"Guenther","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2009.09491.x","article-title":"Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: Results from the PHOENIX 1 trial","volume":"162","author":"Lebwohl","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/jdv.13634","article-title":"Psoriasis registries worldwide: Systematic overview on registry publications","volume":"30","author":"Eissing","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000338572","article-title":"Challenges for synthesising data in a network of registries for systemic psoriasis therapies","volume":"224","author":"Ormerod","year":"2012","journal-title":"Dermatology"},{"key":"ref_62","first-page":"1210","article-title":"PSOLAR: Design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents","volume":"11","author":"Papp","year":"2012","journal-title":"J. Drugs Dermatol."},{"key":"ref_63","first-page":"48","article-title":"German psoriasis registry PsoBest: Objectives, methodology and baseline data","volume":"12","author":"Augustin","year":"2014","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000218161","article-title":"Evaluation of quality of care and guideline-compliant treatment in psoriasis. Development of a new system of quality indicators","volume":"219","author":"Radtke","year":"2009","journal-title":"Dermatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00403-016-1651-x","article-title":"Quality of psoriasis care in Germany: Results of the national health care study \u201cPsoHealth3\u201d","volume":"308","author":"Langenbruch","year":"2016","journal-title":"Arch. Dermatol. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","article-title":"Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey","volume":"70","author":"Lebwohl","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2005.06502.x","article-title":"Current severe psoriasis and the rule of tens","volume":"152","author":"Finlay","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-010-1080-1","article-title":"Definition of treatment goals for moderate to severe psoriasis: A European consensus","volume":"303","author":"Mrowietz","year":"2011","journal-title":"Arch. Dermatol. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/bjd.17128","article-title":"Definition of psoriasis severity in routine clinical care: Current guidelines fail to capture the complexity of long-term psoriasis management","volume":"179","author":"Augustin","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/jdv.14007","article-title":"Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: A systematic review and meta-analysis","volume":"31","author":"Puig","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000113150","article-title":"Relationship between clinical response to therapy and health-related quality of life outcomes in patients with moderate to severe plaque psoriasis","volume":"216","author":"Revicki","year":"2008","journal-title":"Dermatology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/bjd.14788","article-title":"A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis","volume":"176","author":"Ali","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000330560","article-title":"Characterization of patient-reported outcomes in moderate to severe psoriasis","volume":"223","author":"Krenzer","year":"2011","journal-title":"Dermatology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/jid.2011.238","article-title":"Can we rely on the Dermatology Life Quality Index as a measure of the impact of psoriasis or atopic dermatitis?","volume":"132","author":"Twiss","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2340\/00015555-0075","article-title":"Dimensionality of the dermatology life quality index (DLQI): A commentary","volume":"86","author":"Nijsten","year":"2006","journal-title":"Acta Derm. Venereol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/sj.jid.5700875","article-title":"Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients","volume":"127","author":"Nijsten","year":"2007","journal-title":"J. Investig. Dermatol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/sj.jid.5700212","article-title":"Testing and reducing skindex-29 using Rasch analysis: Skindex-17","volume":"126","author":"Nijsten","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1468-3083.2010.03945.x","article-title":"Comparative study of the quality of life of children with atopic dermatitis from Ukraine and the Czech Republic","volume":"25","author":"Chernyshov","year":"2011","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","article-title":"The Skindex instruments to measure the effects of skin disease on quality of life","volume":"30","author":"Chren","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.abd.2020.03.021","article-title":"Validation of the Skindex-17 quality of life assessment instrument for a Brazilian population","volume":"96","author":"Jorge","year":"2021","journal-title":"Bras. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/120347540100500202","article-title":"Measurement properties of Skindex-16: A brief quality-of-life measure for patients with skin diseases","volume":"5","author":"Chren","year":"2001","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/bjd.20765","article-title":"A comparative study on the measurement properties of Dermatology Life Quality Index (DLQI), DLQI-Relevant and Skindex-16","volume":"186","author":"Brodszky","year":"2022","journal-title":"Br. J. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"91s","DOI":"10.1016\/S0197-2456(05)80015-7","article-title":"Evaluating quality-of-life measures for clinical trials in Germany","volume":"12","author":"Bullinger","year":"1991","journal-title":"Control Clin. Trials"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s11136-018-1798-3","article-title":"COSMIN guideline for systematic reviews of patient-reported outcome measures","volume":"27","author":"Prinsen","year":"2018","journal-title":"Qual. Life Res."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s11136-017-1765-4","article-title":"COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures","volume":"27","author":"Mokkink","year":"2018","journal-title":"Qual. Life Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2230.1987.tb01844.x","article-title":"Psoriasis--an index of disability","volume":"12","author":"Finlay","year":"1987","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1001\/jamadermatol.2023.5439","article-title":"Patient-Reported Outcome Measures for Health-Related Quality of Life in Patients With Psoriasis: A Systematic Review","volume":"160","author":"Hopkins","year":"2024","journal-title":"JAMA Dermatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2340\/0001555575240243","article-title":"The Psoriasis Life Stress Inventory: A preliminary index of psoriasis-related stress","volume":"75","author":"Gupta","year":"1995","journal-title":"Acta Derm. Venereol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1365-2133.2000.03418.x","article-title":"The Salford Psoriasis Index: An holistic measure of psoriasis severity","volume":"142","author":"Kirby","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/jid.2013.138","article-title":"The Simplified Psoriasis Index (SPI): A practical tool for assessing psoriasis","volume":"133","author":"Chularojanamontri","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000069253","article-title":"The development of a disease-specific questionnaire to assess quality of life for psoriasis patients: An analysis of the reliability, validity, and responsiveness of the psoriasis quality of life questionnaire","volume":"3","author":"Koo","year":"2002","journal-title":"Dermatol. Psychosom. Dermatol. Psychosom."},{"key":"ref_92","unstructured":"Koo, J., Kozma, C., Menter, A., and Lebwohl, M. (2003, January 21\u201326). Development of a disease specific quality of life questionnaire: The 12-item Psoriasis Quality of Life Questionnaire (PQOL-12). Proceedings of the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, CA, USA."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.det.2011.11.006","article-title":"Quality-of-Life Instruments: Evaluation of the Impact of Psoriasis on Patients","volume":"30","author":"Heller","year":"2012","journal-title":"Dermatol. Clin."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09546634.2012.759639","article-title":"Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity","volume":"24","author":"Martin","year":"2013","journal-title":"J. Dermatol. Treat."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jval.2016.11.020","article-title":"Measurement properties of the psoriasis symptom inventory electronic daily diary in patients with moderate to severe plaque psoriasis","volume":"20","author":"Viswanathan","year":"2017","journal-title":"Value Health"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3109\/09546634.2012.742950","article-title":"Validation of the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure to assess psoriasis symptom severity","volume":"24","author":"Bushnell","year":"2013","journal-title":"J. Dermatol. Treat."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/bjd.12636","article-title":"Impact of brodalumab treatment on psoriasis symptoms and health-related quality of life: Use of a novel patient-reported outcome measure, the Psoriasis Symptom Inventory","volume":"170","author":"Gordon","year":"2014","journal-title":"Br. J. Dermatol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2133.2005.07066.x","article-title":"Refinement and reduction of the Impact of Psoriasis Questionnaire: Classical test theory vs. Rasch analysis","volume":"154","author":"Nijsten","year":"2006","journal-title":"Br. J. Dermatol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11136-018-1829-0","article-title":"COSMIN methodology for evaluating the content validity of patient-reported outcome measures: A Delphi study","volume":"27","author":"Terwee","year":"2018","journal-title":"Qual. Life Res."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1046\/j.1365-2133.2003.05492.x","article-title":"Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials","volume":"149","author":"McKenna","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1111\/j.1524-4733.2004.7s106.x","article-title":"Application of Rasch analysis in the development and application of quality of life instruments","volume":"7","author":"Tennant","year":"2004","journal-title":"Value Health"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.det.2005.05.016","article-title":"A critical review of Quality-of-Life Scales for Psoriasis","volume":"23","author":"Lewis","year":"2005","journal-title":"Dermatol. Clin."},{"key":"ref_103","first-page":"774","article-title":"Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients","volume":"145","author":"Schmidhauser","year":"2009","journal-title":"Arch. Dermatol."},{"key":"ref_104","unstructured":"EMEA\/EMA (2024, June 28). The Regulatory Guidance for the Use of Health-Related Quality of Life (HRQL) Measures in the Evaluation of Medicinal Products. Reflection Paper. CPMP\/EWP\/139391\/04. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/reflection-paper-regulatory-guidance-use-health-related-quality-life-hrql-measures-evaluation-medicinal-products_en.pdf."},{"key":"ref_105","unstructured":"World Health Organization (2024, June 28). WHO Global Report on Psoriasis. Available online: http:\/\/apps.who.int\/iris\/bitstream\/10665\/204417\/1\/9789241565189_eng.pdf."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/jdv.12576","article-title":"Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI)","volume":"29","author":"Eriksson","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Lavrakas, P.J. (2008). Encyclopedia of Survey Research Methods, Sage Publications.","DOI":"10.4135\/9781412963947"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/jamadermatol.2018.1165","article-title":"Identifying a Core Domain Set to Assess Psoriasis in Clinical Trials","volume":"154","author":"Merola","year":"2018","journal-title":"JAMA Dermatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: What do dermatology life quality index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"adv00559","DOI":"10.2340\/00015555-3884","article-title":"Patient-Reported Outcome Measures in Dermatology: A Systematic Review","volume":"101","author":"Pattinson","year":"2021","journal-title":"Acta Derm. Venereol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/jdv.14185","article-title":"Too many instruments for measuring Quality of Life in Atopic Dermatitis","volume":"31","author":"Rzany","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_112","unstructured":"Rasch, G. (1980). Probabilistic Models for Some Intelligence and Attainment Tests, University of Chicago Press."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/10705519609540026","article-title":"Comparing Rasch measurement and factor analysis","volume":"3","author":"Wright","year":"1996","journal-title":"Struct. Equ. Model. A Multidiscip. J."},{"key":"ref_114","unstructured":"Wright, B.D., and Tennant, A. (2024, June 28). Sample Size Again. Available online: https:\/\/www.rasch.org\/rmt\/rmt94h.htm."},{"key":"ref_115","first-page":"273","article-title":"A method for shortening instruments using the Rasch model. Validation on a hand functional measure","volume":"49","author":"Luquet","year":"2001","journal-title":"Rev. Epidemiol. Sante Publique"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7525-1-27","article-title":"Classical Test Theory versus Rasch analysis for quality of life questionnaire reduction","volume":"1","author":"Prieto","year":"2003","journal-title":"Health Qual. Life Outcomes"},{"key":"ref_117","first-page":"80","article-title":"An analysis of dimensionality using factor analysis (true-score theory) and Rasch measurement: What is the difference? Which method is better?","volume":"6","author":"Waugh","year":"2005","journal-title":"J. Appl. Meas."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/jid.2011.354","article-title":"Dermatology life quality index: Time to move forward","volume":"132","author":"Nijsten","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2012.147","article-title":"Dermatology life quality index (DLQI): A paradigm shift to patient-centered outcomes","volume":"132","author":"Finlay","year":"2012","journal-title":"J. Investig. Dermatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2133.2008.08512.x","article-title":"Evaluation of the reimbursement criteria for biological therapies for psoriasis in the Netherlands","volume":"158","author":"Wakkee","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/jdv.13222","article-title":"Use of biologics for psoriasis in Central and Eastern European countries","volume":"29","author":"Rencz","year":"2015","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1468-3083.2006.01565.x","article-title":"Adherence to treatment in patients with psoriasis","volume":"20","author":"Richards","year":"2006","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/bjd.15085","article-title":"Long-term adherence to topical psoriasis treatment can be abysmal: A 1-year randomized intervention study using objective electronic adherence monitoring","volume":"176","author":"Alinia","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2011.08.023","article-title":"Comorbidities significantly impact patients\u2019 preferences for psoriasis treatments","volume":"67","author":"Schmieder","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1365-2133.2012.11217.x","article-title":"Recognition of need in health care consultations: A qualitative study of people with psoriasis","volume":"168","author":"Nelson","year":"2013","journal-title":"Br. J. Dermatol."},{"key":"ref_126","first-page":"Cd011972","article-title":"Lifestyle changes for treating psoriasis","volume":"7","author":"Ko","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2133.2012.11113.x","article-title":"An educational programme for patients with psoriasis and atopic dermatitis: A prospective randomized controlled trial","volume":"167","author":"Bostoen","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/idoj.IDOJ_111_17","article-title":"Effect of an Educational and Psychological Intervention on Knowledge and Quality of Life among Patients with Psoriasis","volume":"9","author":"Nagarajan","year":"2018","journal-title":"Indian. Dermatol. Online J."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/16\/4623\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:31:27Z","timestamp":1760110287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/16\/4623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,7]]},"references-count":128,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["jcm13164623"],"URL":"https:\/\/doi.org\/10.3390\/jcm13164623","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,7]]}}}